Age dependence of modern clinical risk groups for localized prostate cancer—A population-based study
Cancer Jan 29, 2020
Huynh-Le MP, Myklebust TA, Feng CH, et al. - Considering the possible value of age-specific incidence rates (ASIRs) by modern clinical risk groups for informing risk stratification efforts for screening, researchers conducted this cross-sectional population study analyzing men diagnosed with PCa in Norway from 2014 to 2017 (n = 20,356). The patients were assessed for their age, Gleason score (primary plus secondary), and clinical stage. Observations revealed significant association of older age with a higher Gleason score and more advanced disease. The ASIR of high-risk disease was nearly 6 times higher at the ages of 75 to 79 years than the ASIR at 55 to 59 years. Screening seems to be beneficial for healthy older men.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries